TCRX: TScan Therapeutics Inc
今日TCRX汇率已更改5.41%。当日,交易品种以低点0.36和高点0.42进行交易。
关注TScan Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TCRX新闻
- TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study - Slideshow (NASDAQ:TCRX) 2026-09-04
- TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript
- Crude Oil Moves Higher; US Factory Orders Rise In July - Credo Technology Group (NASDAQ:CRDO), Purple Bio
- TScan Reorganizes Pipeline Priorities, Implements Workforce Reduction - TScan Therapeutics (NASDAQ:TCRX)
- Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings - Ollie's Bargain Outlet
- TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Misses Revenue Estimates
- Prime Medicine, Inc. (PRME) Reports Q2 Loss, Misses Revenue Estimates
- TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
- Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com
- Tscan TherapeuticsQ1每股收益及营收超出预期
- Tscan Therapeutics earnings beat by $0.09, revenue topped estimates
- TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates
- TScan completes enrollment in trial cohort, receives FDA clearance
- Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
- Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates
- Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
- Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
常见问题解答
TCRX股票今天的价格是多少?
TScan Therapeutics Inc股票今天的定价为0.39。它在0.36 - 0.42范围内交易,昨天的收盘价为0.37,交易量达到1439。TCRX的实时价格图表显示了这些更新。
TScan Therapeutics Inc股票是否支付股息?
TScan Therapeutics Inc目前的价值为0.39。股息政策取决于公司,而投资者也会关注-78.45%和USD。实时查看图表以跟踪TCRX走势。
如何购买TCRX股票?
您可以以0.39的当前价格购买TScan Therapeutics Inc股票。订单通常设置在0.39或0.69附近,而1439和5.41%显示市场活动。立即关注TCRX的实时图表更新。
如何投资TCRX股票?
投资TScan Therapeutics Inc需要考虑年度范围0.35 - 2.57和当前价格0.39。许多人在以0.39或0.69下订单之前,会比较-45.83%和。实时查看TCRX价格图表,了解每日变化。
TScan Therapeutics Inc股票的最高价格是多少?
在过去一年中,TScan Therapeutics Inc的最高价格是2.57。在0.35 - 2.57内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪TScan Therapeutics Inc的绩效。
TScan Therapeutics Inc股票的最低价格是多少?
TScan Therapeutics Inc(TCRX)的最低价格为0.35。将其与当前的0.39和0.35 - 2.57进行比较,可以发现潜在的长期切入点。观看TCRX在图表上的实时走势以获取更多详细信息。
TCRX股票是什么时候拆分的?
TScan Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、0.37和-78.45%中可见。
- 前一天收盘价
- 0.37
- 开盘价
- 0.37
- 卖价
- 0.39
- 买价
- 0.69
- 最低价
- 0.36
- 最高价
- 0.42
- 交易量
- 1.439 K
- 日变化
- 5.41%
- 月变化
- -45.83%
- 6个月变化
- -60.61%
- 年变化
- -78.45%